Core Team
Our People
Dr. Harry R. Jacobson
Chairman & Strategic Advisor
Physician, entrepreneur, and investor with five decades of healthcare leadership. As CEO of Vanderbilt University Medical Center (1997–2009), grew revenue from $750M to $2.25B and achieved a top-10 NIH funding ranking. Co-founder of Renal Care Group (NYSE, acquired by Fresenius), Contact Software (acquired by Symantec), and CeloNova Biosciences, with a product line sold to Boston Scientific for up to $270M. Former board member of Merck and KCI; elected to the National Academy of Sciences and Tennessee Healthcare Hall of Fame.
Gurdev Chimni
CEO
Strategic relationship builder and healthcare-focused investor with a deep North American network spanning family offices, healthcare executives, and institutional stakeholders. At MedLinks Capital, Gurdev leads deal origination, capital formation, and strategic partnership facilitation across healthcare services, biotechnology, and medical innovation, with investments including Gradalis (oncology immunotherapy) and Virtuoso Surgical (FDA Breakthrough Device designation). A former professional golfer who competed internationally, he brings a relationship-first philosophy shaped by years in high-performance environments.
Andrew Jacobson
Managing Partner
Healthcare investor, co-founder, and capital markets strategist with $100M+ raised across real estate, software, healthcare services, and biotechnology. Andrew has co-founded or led capital raises for MedLogic ($3.25M raised, $65M in claims receivables), CNS Biosciences (Emeramide/Irminix® Phase 2, targeting Progressive Supranuclear Palsy and Parkinson's), Gradalis (FDA RMAT-designated personalised cancer immunotherapy, Phase 3-ready), and Virtuoso Surgical (FDA Breakthrough Device designation). His expertise spans entity formation, exclusive licence negotiation, and cross-border capital facilitation across a high-conviction life sciences portfolio.